Education

All speakers, moderators, and planning committee members involved in an AST educational activity (live or electronic) must disclose any and all relevant financial relationships* of any amount occurring within the past 12 months that they or their spouse/partner have with any commercial interest, defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. *A relevant financial relationship means the relationship(s) creates a potential conflict of interest relevant to the content of the educational activity. Any real or perceived conflict of interest must be resolved prior to finalizing the program. Speakers must also disclose any off label uses of any products they may mention during their presentation.

The AST Conflict of Interest (COI) Committee is responsible for reviewing all disclosures of potential conflicts of interest made by speakers, moderators, and planning committee members. The COI Committee must determine for each reported relationship whether or not that relationship represents an actual conflict of interest relevant to the content of the educational activity, or represents no conflict of interest. If a relationship is found to represent an actual conflict of interest, steps must be taken to resolve/remove the potential conflict of interest. Possible resolutions include altering the nature of the faculty member's relationship with the commercial interest, altering the content of the presentation, or replacing the faculty member.

Reported disclosures and resolutions (if applicable) are displayed below for all AST educational activities; faculty with no reported financial relationships are listed as having no relationships to disclose. Each speaker must also include a disclosure notification at the start of his/her activity and accompany the visual notification with a verbal disclosure if possible; faculty with no reported financial relationships must indicate that they have no relationships to disclose. Additionally, all educational activities will be systematically surveyed for audience perception of bias as part of the post-activity evaluation. Moderators will also be asked to provide feedback from their sessions. 

If you have concerns about a conflict of interest related issue, please contact AST staff at info@myAST.org to reach the Conflict of Interest Committee.

Timely Topics in Transplantation Webinar Series 2014-2015
Timely Topics in Transplantation Webinar Series 2013-2014
Fellows Live Webinar Series 2013-2014
Business of Transplantation Webinar Series 2014


Activity: Timely Topics in Transplantation Webinar Series 2014-2015

Name Role Topic Disclosure of Relevant Financial Relationships Resolution
Gena Boyle, MPA Speaker Kidney Allocation System Changes Nothing to disclose N/A
Kim Brown, MD Speaker Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights Consultant: Blue Cross Transplant Centers of Distinction, Vertex, Genentech, Salix, Merck, Janssen
Grant support: Mass Biologics, Merck, CDC Foundation
Speakers' bureau: HCV Viewpoints, Gilead
No conflicts exist
Robert Brown, MD Moderator Hepatitis C Treatment in Non-liver Solid Organ Transplant Recipients Grant support: Novartis No conflict exists
Lara Danziger-Isakov, MD, MPH Speaker Vaccine Updates in SOT: What's New, What's Standard of Care? Nothing to disclose N/A
Richard Formica, MD Speaker Kidney Allocation System Changes Committee member: UNOS
Co-investigator: Alexion
Advisory Board: BMS
No conflict exists
John Friedewald, MD Speaker Multiorgan Transplantation: One Organ Too Many? Nothing to disclose N/A
Catherine Garvey, RN, BA, CCTC Moderator Medically Complex Living Donors: Candidacy, Care, and Informed Consent Nothing to disclose N/A
Elisa Gordon, PhD, MPH Speaker Medically Complex Living Donors: Candidacy, Care, and Informed Consent Nothing to disclose N/A
Peter Heeger, MD Speaker Monitoring the Alloresponse Before and After Transplantation Nothing to disclose N/A
Atul Humar, MD Speaker Cytomegalovirus: Prevention, Therapy, Immunity Consultant: Astellas, Chimerix
Grant support: Roche
No conflict exists
Shirish Huprikar, MD Moderator Cytomegalovirus: Prevention, Therapy, Immunity Consultant: Oxford Immunotec, Sunshine Heart
Grant support: Astellas
No conflict exists
Tiffany Kaiser, PharmD Speaker Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights Nothing to disclose N/A
Jon Kobashigawa, MD Speaker Treatment of Antibody-mediated Rejection in Thoracic Transplants

Grant support: Novartis, CareDx, Inc.
Consultant: Novartis

No conflict exists
Camille Kotton, MD Speaker Cytomegalovirus: Prevention, Therapy, Immunity Consultant: Roche, Merck, Astellas, Cellestis, Oxford Immunotec No conflict exists
Deepali Kumar, MD Speaker Vaccine Updates in SOT: What's New, What's Standard of Care? Grant support: Roche, GlaxoSmithKline
Speakers' bureau: Pfizer, Merck
Consultant: Oxford Immunotec, Roche
Unrestricted research grant: Astellas
Research materials: Qiagen
No conflict exists
Josh Levitsky, MD Moderator Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights Consultant: Transplant Genomics, Inc., Abbvie
Speaker's Bureau: Gilead, Salix
No conflict exists
Matt Morrell, MD Speaker Treatment of Antibody-mediated Rejection in Thoracic Transplants  Nothing to disclose N/A
Thomas Mueller, MD, PhD Speaker World Transplant Congress 2014: Clinical Highlights Nothing to disclose N/A
Christian Oberkofler, MD Speaker World Transplant Congress 2014: Clinical Highlights Nothing to disclose N/A
Raymund Razonable, MD Speaker Cytomegalovirus: Prevention, Therapy, Immunity Nothing to disclose N/A
Peter Reese, MD, MSCE Speaker Multiorgan Transplantation: One Organ Too Many? Nothing to disclose N/A
Leonardo Riella, MD, PhD Moderator Monitoring the Alloresponse Before and After Transplantation Nothing to disclose N/A
David Serur, MD Speaker Medically Complex Living Donors: Candidacy, Care, and Informed Consent Awaiting disclosure TBD
Norah Terrault, MD, MPH Speaker Hepatitis C Treatment in Non-liver Solid Organ Transplant Recipients Nothing to disclose N/A
Jason Wertheim, MD Moderator Multiorgan Transplantation: One Organ Too Many? Honorarium: Center for the Advancement of Science in Space, Provincial Health Services Authority
Grant Support: NIH/NIDDK, ASTS, NKF Illinois, AASLD
Stipent: Landes Bioscience
No conflict exists
Julie Yabu, MD Moderator Treatment of Antibody-mediated Rejection in Thoracic Transplants Consultant (one-time): CareDx No conflict exists

Activity: Timely Topics in Transplantation Webinar Series 2013-2014

Name Role Topic Disclosure of Relevant Financial Relationships Resolution
Mark Haas, MD, PhD Speaker Banff Conference on Allograft Pathology: 2013 Summary Nothing to disclose N/A
Michael Mengel, MD Moderator Banff Conference on Allograft Pathology: 2013 Summary Nothing to disclose N/A
Camille Kotton, MD Speaker Updates on International CMV Consensus Guidelines and the AST Infectious Disease Guidelines 3rd Edition Consultant: Astellas, Cellestis, Merck, Oxford Immunotec, Roche Diagnostics No conflict exists
Deepali Kumar, MD Moderator Updates on International CMV Consensus Guidelines and the AST Infectious Disease Guidelines 3rd Edition Grant Support: Roche
Speakers' Bureau: Astellas, Merck Pfizer
No conflict exists
Peter Stock, MD, PhD Speaker International Pancreas and Islet Transplant Association World Congress: 2013 Summary Nothing to disclose N/A
Nicole Turgeon, MD Moderator International Pancreas and Islet Transplant Association World Congress: 2013 Summary Nothing to disclose N/A
Seth Heldenbrand, MD Speaker Adherence Tools of Today and Tomorrow: Improving Adherence in the Challenging Transplant Patient Nothing to disclose N/A
Jennifer Trofe-Clark, PharmD Moderator Adherence Tools of Today and Tomorrow: Improving Adherence in the Challenging Transplant Patient Consultant: Catapult Consultants, LexiComp
Grant Support: Veloxis Pharmaceuticals
No conflict exists
John Friedewald, MD Speaker Update on Kidney Allocation Nothing to disclose N/A
Mark Aeder, MD Moderator Update on Kidney Allocation Nothing to disclose N/A
Jennifer Milton, BSN, MBA, CCTC Speaker Complying with New UNOS Living Donor Care Policies Spouse is COO of XynManagement No conflict exists
Rebecca Hays, MSW, APSW Moderator Complying with New UNOS Living Donor Care Policies Nothing to disclose N/A
Jacqueline O'Leary, MD, PhD Speaker Hepatitis C Eradication: Liver Transplant Patients and Beyond Speakers' bureau: Genentech, Gilead, Vertex
Investments: Medfusion
Consultant: Janssen
No conflict exists
Kimberly Brown, MD Speaker Hepatitis C Eradication: Liver Transplant Patients and Beyond Consultant: Blue Cross Centers of Distinction, Genentech, Salix, Vertex
Advisory Board: Janssen, Merck
Speakers' bureau: Gilead, HCV Viewpoints
Board and education activity: Chronic Liver Disease Foundation
Grant support: CDC Foundation, Mass Biologics, Merck
Associate editor: CLD journal, AJT Images in Transplantation
No conflict exists
Robert Gaston, MD Speaker A Discussion of Risk in Living Kidney Donors Nothing to disclose N/A
William McClellan, MD, MPH Speaker A Discussion of Risk in Living Kidney Donors Nothing to disclose N/A
Arthur Matas, MD Speaker A Discussion of Risk in Living Kidney Donors Nothing to disclose N/A
Nicole Turgeon, MD Speaker A Discussion of Risk in Living Kidney Donors Nothing to disclose N/A
Kathryn Tinckam, MD Speaker Role of HLA Testing in Pre- and Post-transplant Monitoring for SOT: What it Can and Cannot Tell Us Nothing to disclose N/A
Vineeta Kumar, MD Moderator Role of HLA Testing in Pre- and Post-transplant Monitoring for SOT: What it Can and Cannot Tell Us Nothing to disclose N/A

Activity: Fellows Live Webinar Series 2013-2014

Name Role Topic Disclosure of Relevant Financial Relationships Resolution
Yolanda Becker, MD Speaker Ethics in Transplantation Nothing to disclose N/A
David Wojciechowski, DO Speaker Ethics in Transplantation Nothing to disclose N/A
Naima Carter-Monroe, MD Speaker Pathology Nothing to disclose N/A
Lorraine Racusen, MD Speaker Pathology Nothing to disclose N/A
E. Rene Rodriguez, MD Speaker Pathology Nothing to disclose N/A
Nitika Gupta, MD Speaker Pathology Nothing to disclose N/A
Murli Krishna, MD Speaker Pathology Nothing to disclose N/A
Jamil Azzi, MD Speaker Future of Translational Research Nothing to disclose N/A
Leonardo Riella, MD, PhD Speaker Future of Translational Research Grant Support: American Heart Association No conflict exists
Peter Heeger, MD Speaker Future of Translational Research Nothing to disclose N/A
Nicole Theodoropoulos, MD Speaker Should I Accept this Donor? Nothing to disclose N/A
Michael Ison, MD Speaker Should I Accept this Donor? Nothing to disclose N/A
Dorry Segev, MD Speaker Should I Accept this Donor? Nothing to disclose N/A
Rita Alloway, PharmD Speaker Generic Immunosuppressants Grant Support: Astellas, Alexion, BMS
Consultant: Up-to-Date
No conflict exists
Simon Tremblay, PharmD Speaker Generic Immunosuppressants Nothing to disclose N/A
Manjushree Gautam, MD Speaker Malignancies after Solid Organ Transplantation Nothing to disclose N/A
John Gill, MD Speaker Malignancies after Solid Organ Transplantation Nothing to disclose N/A

Activity: Business of Transplantation Webinar Series 2014

Name Role Topic Disclosure of Relevant Financial Relationships Resolution
Jesse Schold, PhD, MStat, MEd Speaker Understanding CUSUM and Bayesian Charts: New SRTR Transplant Reporting Methodologies Nothing to disclose N/A
Lisa Stocks, RN, MSN, FNP Speaker OPO Quality Program Nothing to disclose N/A
Kevin Myer, MSHA Speaker OPO and Transplant Center Collaborations Nothing to disclose N/A
William Vaughan Speaker OPO Finance Consultant: Guidry & East  
Jon Friedman, MD Speaker Optum Nothing to disclose N/A
Patricia Martin, RN, BSN Speaker WellPoint, Inc. Nothing to disclose N/A
Thomas Hamilton, MA Speaker Centers for Medicare and Medicaid Services Nothing to disclose N/A

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.